共 48 条
- [1] Consolidation Anti-CD22 Fractionated Radioimmunotherapy with 90y-Epratuzumab Tetraxetan Following R-CHOP in Elderly DLBCL Patients: A Lysa Phase II Prospective TrialBLOOD, 2012, 120 (21)Kraeber-Bodere, Francoise论文数: 0 引用数: 0 h-index: 0机构: CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FrancePallardy, Amandine论文数: 0 引用数: 0 h-index: 0机构: CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceLe Gouill, Steven论文数: 0 引用数: 0 h-index: 0机构: Univ Nantes, Inserm U892, Nantes, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceMaisonneuve, Herve论文数: 0 引用数: 0 h-index: 0机构: CH La Roche Yon, La Roche Sur Yon, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceLamy, Thierry论文数: 0 引用数: 0 h-index: 0机构: CHU Rennes, Rennes, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceBouabdallah, Krimo论文数: 0 引用数: 0 h-index: 0机构: Hop Haut Leveque, Serv Hematol Clin & Therapie Cellulaire, Pessac, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceMilpied, Noel论文数: 0 引用数: 0 h-index: 0机构: Hop Haut Leveque, CHU Bordeaux, Pessac, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceJardel, Henry论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Bretagne Atlant, Serv Med Interne, Vannes, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceDeconinck, Eric论文数: 0 引用数: 0 h-index: 0机构: CHU Besancon, F-25030 Besancon, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceMorineau, Nadine论文数: 0 引用数: 0 h-index: 0机构: Ctr Catherine Sienne, Nantes, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceFoussard, Charles论文数: 0 引用数: 0 h-index: 0机构: CHU Angers, Serv Malad Sang, Angers, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceBrion, Annie论文数: 0 引用数: 0 h-index: 0机构: CHU Besancon, F-25030 Besancon, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceGressin, Remy论文数: 0 引用数: 0 h-index: 0机构: CHU Grenoble, Inst Albert Bonniot, INSERM, U823, F-38043 Grenoble, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceTournilhac, Olivier论文数: 0 引用数: 0 h-index: 0机构: Univ Auvergne EA3846, Serv Therapie Cellulaire & Hematol Clin Adulte, Inserm CIC 501, Univ Hosp Estaing, Clermont Ferrand, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceGyan, Emmanuel论文数: 0 引用数: 0 h-index: 0机构: CHU Tours, Serv Hematol & Therapie Cellulaire, Tours, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceMoreau, Anne论文数: 0 引用数: 0 h-index: 0机构: CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceBerthou, Christian论文数: 0 引用数: 0 h-index: 0机构: Brest Univ Hosp, Brest, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceDreyfus, Francois论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, Cochin Hosp, APHP, Paris, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceBodet-Milin, Caroline论文数: 0 引用数: 0 h-index: 0机构: CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceCazeau, Anne-Laure论文数: 0 引用数: 0 h-index: 0机构: Inst Bergonie, Serv Med Nucl, Bordeaux, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceGarin, Etienne论文数: 0 引用数: 0 h-index: 0机构: CHU Rennes, Rennes, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceVuillez, Jean-Philippe论文数: 0 引用数: 0 h-index: 0机构: CHU Michallon, Serv Med Nucl, Grenoble, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceCampion, Loic论文数: 0 引用数: 0 h-index: 0机构: Inst Cancerol Ouest, St Herblain, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceMoreau, Philippe论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Hotel Dieu, Dept Hematol, Nantes, France CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceWegener, William A.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics, Morris Plains, NJ USA CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceGoldenberg, David M.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics Inc, R&D, Morris Plains, NJ USA CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, FranceSoubeyran, Pierre论文数: 0 引用数: 0 h-index: 0机构: CHU Nantes, Nucl Med Serv, F-44035 Nantes 01, France
- [2] Consolidation anti-CD22 fractionated radioimmunotherapy (RIT) with 90Y-epratuzumab tetraxetan following R-CHOP in elderly diffuse large B-cell lymphoma (DLBCL) patientsJOURNAL OF NUCLEAR MEDICINE, 2011, 52Pallardy, Amandine论文数: 0 引用数: 0 h-index: 0机构: Hop Hotel Dieu, Nantes, France Hop Hotel Dieu, Nantes, FranceSoubeyran, Pierre论文数: 0 引用数: 0 h-index: 0机构: Bergonie Ctr, Bordeaux, France Hop Hotel Dieu, Nantes, FranceLe Gouill, Steven论文数: 0 引用数: 0 h-index: 0机构: Hop Hotel Dieu, Nantes, France Hop Hotel Dieu, Nantes, FranceBodet-Milin, Caroline论文数: 0 引用数: 0 h-index: 0机构: Hop Hotel Dieu, Nantes, France Hop Hotel Dieu, Nantes, FranceFaivre-Chauvet, Alain论文数: 0 引用数: 0 h-index: 0机构: Hop Hotel Dieu, Nantes, France Hop Hotel Dieu, Nantes, FranceGarin, Etienne论文数: 0 引用数: 0 h-index: 0机构: Eugene Marquis Ctr, Rennes, France Hop Hotel Dieu, Nantes, FranceVuillez, Jean-Philippe论文数: 0 引用数: 0 h-index: 0机构: CHU, Grenoble, France Hop Hotel Dieu, Nantes, FranceWegener, William论文数: 0 引用数: 0 h-index: 0机构: Immunomed, Morris Plains, NJ USA Hop Hotel Dieu, Nantes, FranceGoldenberg, David论文数: 0 引用数: 0 h-index: 0机构: Ctr Mol Med & Immunol, Morris Plains, NJ USA Hop Hotel Dieu, Nantes, FranceKraeber-Bodere, Francoise论文数: 0 引用数: 0 h-index: 0机构: Hop Hotel Dieu, Nantes, France Hop Hotel Dieu, Nantes, France
- [3] Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trialLANCET HAEMATOLOGY, 2017, 4 (01): : E35 - E45Kraeber-Bodere, Francoise论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, France Inst Cancerol Ouest Canc Ctr, St Herblain, France Univ Hosp, Nantes, FrancePallardy, Amandine论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, France Univ Hosp, Nantes, FranceMaisonneuve, Herve论文数: 0 引用数: 0 h-index: 0机构: Dept Haematol, La Roche Sur Yon, France Univ Hosp, Nantes, FranceCampion, Loic论文数: 0 引用数: 0 h-index: 0机构: Inst Cancerol Ouest Canc Ctr, St Herblain, France Univ Hosp, Nantes, FranceMoreau, Anne论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, France Univ Hosp, Nantes, FranceSoubeyran, Isabelle论文数: 0 引用数: 0 h-index: 0机构: Inst Bergonie, Ctr Canc, Bordeaux, France Univ Bordeaux, Bordeaux, France Univ Hosp, Nantes, FranceLe Gouill, Steven论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, France Univ Hosp, Nantes, FranceTournilhac, Olivier论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Clermont Ferrand, France Univ Hosp, Nantes, FranceDaguindau, Etienne论文数: 0 引用数: 0 h-index: 0机构: Jean Minjoz Hosp, Besancon, France Univ Hosp, Nantes, FranceJardel, Henry论文数: 0 引用数: 0 h-index: 0机构: Bretagne Atlantique, Vannes, France Univ Hosp, Nantes, FranceMorineau, Nadine论文数: 0 引用数: 0 h-index: 0机构: Catherine de Sienne Ctr, Nantes, France Univ Hosp, Nantes, FranceBouabdallah, Krimo论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Haut Leveque, Bordeaux, France Univ Hosp, Nantes, FranceGyan, Emmanuel论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, GICC UMR CNRS 7292, INSERM U1415, Hematol & Cell Therapy Dept,Clin Invest Ctr, Tours, France Univ Hosp, Nantes, FranceMoles, Marie-Pierre论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Angers, France Univ Hosp, Nantes, FranceGressin, Remy论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Grenoble, France Univ Hosp, Nantes, FranceBerthou, Christian论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Brest, France Univ Hosp, Nantes, FranceSadot, Sophie论文数: 0 引用数: 0 h-index: 0机构: Inst Cancerol Ouest Canc Ctr, St Herblain, France Univ Hosp, Nantes, FranceMoreau, Philippe论文数: 0 引用数: 0 h-index: 0机构: Hop Scorff, Lorient, France Univ Hosp, Nantes, FranceDeau, Benedicte论文数: 0 引用数: 0 h-index: 0机构: Cochin Hosp, AP HP, Paris, France Univ Hosp, Nantes, FranceBodet-Milin, Caroline论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, France Univ Hosp, Nantes, FranceCazeau, Anne-Laure论文数: 0 引用数: 0 h-index: 0机构: Inst Bergonie, Ctr Canc, Bordeaux, France Univ Bordeaux, Bordeaux, France Univ Hosp, Nantes, FranceGarin, Etienne论文数: 0 引用数: 0 h-index: 0机构: Eugene Marquis Canc Ctr, Rennes, France Univ Hosp, Nantes, FranceSalaun, Pierre-Yves论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Brest, France Univ Hosp, Nantes, FranceVuillez, Jean-Philippe论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Grenoble, France Univ Hosp, Nantes, FranceGouilleux-Gruart, Valerie论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, GICC UMR CNRS 7292, INSERM U1415, Hematol & Cell Therapy Dept,Clin Invest Ctr, Tours, France Univ Hosp, Nantes, FranceBarbet, Jacques论文数: 0 引用数: 0 h-index: 0机构: Grp Interet Publ Arronax, Arronax, St Herblain, France Univ Hosp, Nantes, FranceWegener, William A.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics, Clin Res, Morris Plains, NJ USA Univ Hosp, Nantes, FranceGoldenberg, David M.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics, Clin Res, Morris Plains, NJ USA Univ Hosp, Nantes, FranceLamy, Thierry论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Rennes, France Univ Hosp, Nantes, FranceSoubeyran, Pierre论文数: 0 引用数: 0 h-index: 0机构: Inst Bergonie, Ctr Canc, Bordeaux, France Univ Bordeaux, Bordeaux, France Univ Hosp, Nantes, France
- [4] Clinical update on fractionated radioimmunotherapy in patients with NHL using humanized 90Y labeled anti-CD22 epratuzumabANNALS OF ONCOLOGY, 2005, 16 : 68 - 69Chatal, J论文数: 0 引用数: 0 h-index: 0机构: INSERM, REs Unit 463, Grp Biophys Cancerol, Nantes, FranceHarousseau, J论文数: 0 引用数: 0 h-index: 0机构: INSERM, REs Unit 463, Grp Biophys Cancerol, Nantes, FranceGriesinger, F论文数: 0 引用数: 0 h-index: 0机构: INSERM, REs Unit 463, Grp Biophys Cancerol, Nantes, FranceMeller, J论文数: 0 引用数: 0 h-index: 0机构: INSERM, REs Unit 463, Grp Biophys Cancerol, Nantes, FrancePfreundschuh, M论文数: 0 引用数: 0 h-index: 0机构: INSERM, REs Unit 463, Grp Biophys Cancerol, Nantes, FranceKirsch, C论文数: 0 引用数: 0 h-index: 0机构: INSERM, REs Unit 463, Grp Biophys Cancerol, Nantes, FranceNaumann, R论文数: 0 引用数: 0 h-index: 0机构: INSERM, REs Unit 463, Grp Biophys Cancerol, Nantes, FranceKropp, J论文数: 0 引用数: 0 h-index: 0机构: INSERM, REs Unit 463, Grp Biophys Cancerol, Nantes, FranceMorschhauser, F论文数: 0 引用数: 0 h-index: 0机构: INSERM, REs Unit 463, Grp Biophys Cancerol, Nantes, FranceHuglo, D论文数: 0 引用数: 0 h-index: 0机构: INSERM, REs Unit 463, Grp Biophys Cancerol, Nantes, France
- [5] Radioimmunotherapy in NHL at high cumulative doses of 90Y with fractionated doses of dota-conjugated, humanized anti-CD22 IGG, epratuzumabANNALS OF ONCOLOGY, 2008, 19 : 88 - 88Morschhauser, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Lille, Centre Hospitalier Reg, Dept Hematol, Lille, France Univ Lille, Centre Hospitalier Reg, Dept Hematol, Lille, FranceKraeber-Bodere, F.论文数: 0 引用数: 0 h-index: 0机构: Inst Biol, INSERM, Res Unit 4, Nantes, France Univ Lille, Centre Hospitalier Reg, Dept Hematol, Lille, FranceHuglo, D.论文数: 0 引用数: 0 h-index: 0机构: Univ Lille, Centre Hospitalier Reg, Dept Hematol, Lille, France Univ Lille, Centre Hospitalier Reg, Dept Hematol, Lille, FrancePetillon, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Lille, Centre Hospitalier Reg, Dept Hematol, Lille, France Univ Lille, Centre Hospitalier Reg, Dept Hematol, Lille, FranceChatal, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Lille, Centre Hospitalier Reg, Dept Hematol, Lille, France Univ Lille, Centre Hospitalier Reg, Dept Hematol, Lille, FranceHarousseau, J.论文数: 0 引用数: 0 h-index: 0机构: CHU Nantes, Serv Hematol, F-44035 Nantes 01, France Univ Lille, Centre Hospitalier Reg, Dept Hematol, Lille, FranceHome, H.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics Inc, Dept Clin Res, Morris Plains, NJ USA Univ Lille, Centre Hospitalier Reg, Dept Hematol, Lille, FranceTeoh, N.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics Inc, Dept Clin Res, Morris Plains, NJ USA Univ Lille, Centre Hospitalier Reg, Dept Hematol, Lille, FranceWegener, W. A.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics Inc, Dept Clin Res, Morris Plains, NJ USA Univ Lille, Centre Hospitalier Reg, Dept Hematol, Lille, FranceGoldenberg, D. M.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics Inc, Dept Clin Res, Morris Plains, NJ USA Univ Lille, Centre Hospitalier Reg, Dept Hematol, Lille, France
- [6] Fractionated radioimmunotherapy in NHL with DOTA-conjugated, humanized anti-CD22 IgG, epratuzumab: Results at high cumulative doses of 90YJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Kraeber-Bodere, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, FranceMorschhauser, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, FranceHuglo, D.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, FrancePetillon, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, FranceChatal, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, FranceHarousseau, J. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, FranceHorne, H.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, FranceTeoh, N.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, FranceWegener, W. A.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, FranceGoldenberg, D. M.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Nantes, France
- [7] FDG-PET predicts response to fractionated radioimmunotherapy with 90Y-epratuzumab anti-CD22 MAB in patients with NHL.BLOOD, 2005, 106 (11) : 275B - 276BBodet-Milin, C论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Dept Nucl Med, Nantes, FranceRousseau, C论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Dept Nucl Med, Nantes, FranceCampion, L论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Dept Nucl Med, Nantes, FranceAnsquer, C论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Dept Nucl Med, Nantes, FranceDupas, B论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Dept Nucl Med, Nantes, FranceMilpied, N论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Dept Nucl Med, Nantes, FranceMahe, B论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Dept Nucl Med, Nantes, FranceChatal, JF论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Dept Nucl Med, Nantes, FranceWegener, WA论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Dept Nucl Med, Nantes, FranceGoldenberg, DM论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Dept Nucl Med, Nantes, FranceKraeber-Bodere, F论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Dept Nucl Med, Nantes, France
- [8] Final results of a Phase I/II trial of fractionated radioimmunotherapy (RAIT) with anti-CD22 90Y-epratuzumab tetraxetan in relapsed/refractory non-Hodgkin lymphoma (NHL)EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S237 - S237Goldenberg, D. M.论文数: 0 引用数: 0 h-index: 0机构: Garden State Canc Ctr, Belleville, NJ USA Garden State Canc Ctr, Belleville, NJ USAKraeber-Bodere, F.论文数: 0 引用数: 0 h-index: 0机构: IRCNA, Ctr Rene Gauducheau, Nantes, France Garden State Canc Ctr, Belleville, NJ USAMorschhauser, F.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Reg, Lille, France Garden State Canc Ctr, Belleville, NJ USAPetillon, M.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Reg, Lille, France Garden State Canc Ctr, Belleville, NJ USAHuglo, D.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Reg, Lille, France Garden State Canc Ctr, Belleville, NJ USAMeller, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Gottingen, Gottingen, Germany Garden State Canc Ctr, Belleville, NJ USAKirsch, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Saarland, Sch Med, D-6650 Homburg, Germany Garden State Canc Ctr, Belleville, NJ USAKropp, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Dresden, Dresden, Germany Garden State Canc Ctr, Belleville, NJ USALe Gouil, S.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ, Nantes, France Garden State Canc Ctr, Belleville, NJ USALe Gouil, S.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ, Nantes, France Garden State Canc Ctr, Belleville, NJ USABodet-Milin, C.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ, Nantes, France Garden State Canc Ctr, Belleville, NJ USATeoh, N.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics Inc, Morris Plains, NJ USA Garden State Canc Ctr, Belleville, NJ USAChatal, J.论文数: 0 引用数: 0 h-index: 0机构: IRCNA, Ctr Rene Gauducheau, Nantes, France Garden State Canc Ctr, Belleville, NJ USAWegener, W. A.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics Inc, Morris Plains, NJ USA Garden State Canc Ctr, Belleville, NJ USA
- [9] Fractionated radioimmunotherapy in NHL with dota-conjugated, humanized anti-CD22 epratuzumabat high cumulative 90Y dosesHAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 151 - 151Morschhauser, F.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp, Lille, FranceKraeber-Bodere, F.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp, Lille, FrancePetillon, M.-O.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp, Lille, FranceChatal, J.-F.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp, Lille, FranceHarousseau, J.-L.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp, Lille, FranceHorne, H.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp, Lille, FranceTeoh, N.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp, Lille, FranceWegener, W. A.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp, Lille, FranceGoldenberg, D. M.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp, Lille, France
- [10] Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphomaHAEMATOLOGICA, 2014, 99 (11) : 1738 - 1745Witzig, Thomas E.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Mayo Clin, Rochester, MN USATomblyn, Michael B.论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA Mayo Clin, Rochester, MN USAMisleh, Jamal G.论文数: 0 引用数: 0 h-index: 0机构: Helen F Graham Canc Ctr, Newark, DE USA Mayo Clin, Rochester, MN USAKio, Ebenezer A.论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ, Hlth Ctr Canc Care, Goshen, IN USA Mayo Clin, Rochester, MN USASharkey, Robert M.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics, Morris Plains, NJ 07950 USA Mayo Clin, Rochester, MN USAWegener, William A.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics, Morris Plains, NJ 07950 USA Mayo Clin, Rochester, MN USAGoldenberg, David M.论文数: 0 引用数: 0 h-index: 0机构: Immunomedics, Morris Plains, NJ 07950 USA Ctr Mol Med & Immunol, Garden State Canc Ctr, Morris Plains, NJ USA Mayo Clin, Rochester, MN USA